WSTAM
ECYT

Wilbanks Smith & Thomas Asset Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$18K – 1553
2018
Q3 		$18K Buy
+1,000
New +$18K ﹤0.01% 919